S. 3258 — Aviation Medication Transparency Act of 2026

This section requires the Federal Aviation Administration to publish and maintain, within 1 year of enactment, a publicly available list of medications approved for use by airmen and air traffic control specialists seeking medical certification or clearance. The list must identify medications that may be safely prescribed or purchased over the counter, note contraindications and any required FAA review, include all “Do Not Issue” and “Do Not Fly” medications, indicate minimum stabilization periods where practicable, and be accessible via MedXPress. The Administrator must consult specified aviation and medical stakeholder groups before publication and update the list at least annually or when the Guide for Aviation Medical Examiners changes.